4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Autolus Therapeutics plc (AUTL) operates in the Biotechnology industry and is headquartered in London, United Kingdom with about 752 employees. Its market capitalization is roughly $596 million. In the fiscal year ended 2025-12-31, AUTL reported $75M in revenue and ($288M) in net income.
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally.
Interactive charts & full statements → Open the AUTL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $75M | $10M | $2M | $6M | — |
| Gross Profit | ($21M) | ($1M) | $2M | — | — |
| Operating Income (EBIT) | ($270M) | ($241M) | ($176M) | ($143M) | — |
| Net Income | ($288M) | ($221M) | ($208M) | ($149M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $46M | $26M | $24M | $21M | $21M | — | — |
| Gross Profit | $25M | $2M | ($1M) | ($7M) | ($4M) | — | — |
| Operating Income (EBIT) | ($44M) | ($60M) | ($72M) | ($72M) | ($61M) | — | — |
| Net Income | ($39M) | ($72M) | ($90M) | ($79M) | ($48M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $589M | $783M | $375M | $490M | — |
| Total Liabilities | $411M | $355M | $264M | $192M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AUTL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms